Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Non-nucleoside reverse transcriptase inhibitors described by Roche Bioscience

Nov. 15, 2004

Canadian HIV Trials Network lends support to phase I/II study of IR-103

Nov. 15, 2004

Phase II study investigates Racivir for HIV

Nov. 15, 2004

Potent inhibition of HIV entry by CCR5 mAb

Nov. 10, 2004

Panacos amends merger agreement with V.I. Technologies

Nov. 10, 2004

Phase II data support 873140 as an antiviral for HIV infection

Nov. 9, 2004

Add-on therapy with Reverset reduces viral load in HIV-infected patients

Nov. 9, 2004

Shionogi scientists present new HIV integrase inhibitors

Nov. 8, 2004

Novel low molecular weight anti-HIV agents by Merck & Co.

Nov. 4, 2004

Tipranavir/ritonavir shows antiviral efficacy in advanced HIV disease

Nov. 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...